Aidoc Secures New FDA Clearances Enabling Faster and More Accurate Detection of Critical Neurological and Cardiovascular Conditions
Retrieved on:
Thursday, November 17, 2022
Triage, AD, LVO, Thoracic aortic aneurysm, EHR, Surgery, Stroke, Length of stay, Mevo, Radiology, Physician, M1, FDA, Doctor Foster, Aidoc, ICA, Computer-aided simple triage, Intelligence, Abdominal aortic aneurysm, Middle cerebral artery, Anterior cerebral artery, Patient, PCA, COVID-19, Pressure, Surgeon, Communication, Basilar artery, Posterior cerebral artery, Brain, Vos, MCA, AI, Vertebral artery, ACA, Ambient occlusion, Yale New Haven Hospital, CT, Medical device, Medicine, Medical imaging, Mevo Modi'im
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today announced it has increased its FDA clearances to 11 with the addition of CT-based AI solutions - aortic dissection (AD) and all vessel occlusions (VOs). These clearances continue Aidoc's impressive momentum and leadership in healthcare AI, giving the organization the most FDA clearances in the AI imaging space.
Key Points:
- These clearances continue Aidoc's impressive momentum and leadership in healthcare AI, giving the organization the most FDA clearances in the AI imaging space.
- "Effective healthcare and treatment of acute conditions, like stroke and aortic dissections, require rapid, coordinated care minutes can matter," said Aidoc CEO Elad Walach.
- Aidoc is the only company with a proven EHR integration for the population of critical, time-sensitive patient information on the app.
- Aidoc is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance quality of care.